Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammatory mediators and late-onset Alzheimer’s disease risk factors | Synapse
March 3, 2026
Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammatory mediators and late-onset Alzheimer’s disease risk factors
Key Points
Inhibition of ripk1 kinase leads to decreased expression of proinflammatory mediators.
Key evidence shows significant reduction in inflammatory markers linked to alzheimer's disease.
Assessment of ripk1's role in mediating inflammation used experimental models to draw interactions.
These findings highlight potential new strategies for addressing late-onset Alzheimer's disease.